165 related articles for article (PubMed ID: 37599359)
1. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract][Full Text] [Related]
2. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
3. METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation.
Pandolfini L; Barbieri I; Bannister AJ; Hendrick A; Andrews B; Webster N; Murat P; Mach P; Brandi R; Robson SC; Migliori V; Alendar A; d'Onofrio M; Balasubramanian S; Kouzarides T
Mol Cell; 2019 Jun; 74(6):1278-1290.e9. PubMed ID: 31031083
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.
Zhang C; Cui Y
Biol Chem; 2024 Mar; 405(3):217-228. PubMed ID: 37694982
[TBL] [Abstract][Full Text] [Related]
5. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
6. m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation.
Zhao Y; Kong L; Pei Z; Li F; Li C; Sun X; Shi B; Ge J
Front Cell Dev Biol; 2021; 9():642080. PubMed ID: 34136476
[TBL] [Abstract][Full Text] [Related]
7. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
[TBL] [Abstract][Full Text] [Related]
8. METTL1 promotes hepatocarcinogenesis via m
Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α/METTL1/m
Mi S; Cai S; Xue M; Wu W
Biochem Biophys Res Commun; 2024 Jan; 693():149385. PubMed ID: 38118310
[TBL] [Abstract][Full Text] [Related]
10. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
11. METTL1-m
Ying X; Liu B; Yuan Z; Huang Y; Chen C; Jiang X; Zhang H; Qi D; Yang S; Lin S; Luo J; Ji W
Clin Transl Med; 2021 Dec; 11(12):e675. PubMed ID: 34936728
[TBL] [Abstract][Full Text] [Related]
12. METTL1 mediated tRNA m
Zhao P; Xia L; Chen D; Xu W; Guo H; Xu Y; Yan B; Wu X; Li Y; Zhang Y; Zhang X
Exp Hematol Oncol; 2024 Jan; 13(1):8. PubMed ID: 38268051
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma.
Chen J; Zhou Q; Li S; Ling R; Zhao Y; Chen D; Wang A; Cao Y
Transl Res; 2024 Jun; 268():28-39. PubMed ID: 38280546
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-specific knockout of METTL1 attenuates myocardial infarction-induced cardiac fibrosis.
Wang L; Zhou J; Kong L; Ying G; Sha J; Yi D; Zeng J; Xiong W; Wen T
Life Sci; 2023 Sep; 329():121926. PubMed ID: 37437652
[TBL] [Abstract][Full Text] [Related]
15. METTL1-mediated m
Deng Y; Zhou Z; Ji W; Lin S; Wang M
Stem Cell Res Ther; 2020 Jul; 11(1):306. PubMed ID: 32698871
[TBL] [Abstract][Full Text] [Related]
16. METTL1/WDR4-mediated m
Ma J; Han H; Huang Y; Yang C; Zheng S; Cai T; Bi J; Huang X; Liu R; Huang L; Luo Y; Li W; Lin S
Mol Ther; 2021 Dec; 29(12):3422-3435. PubMed ID: 34371184
[TBL] [Abstract][Full Text] [Related]
17. METTL1 promotes neuroblastoma development through m
Huang Y; Ma J; Yang C; Wei P; Yang M; Han H; Chen HD; Yue T; Xiao S; Chen X; Li Z; Tang Y; Luo J; Lin S; Huang L
Biomark Res; 2022 Sep; 10(1):68. PubMed ID: 36071474
[TBL] [Abstract][Full Text] [Related]
18. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
Xu F; Cai D; Liu S; He K; Chen J; Qu L; Chong T; Li X; Ren B
Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
[TBL] [Abstract][Full Text] [Related]
19. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
20. N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer.
Cai M; Yang C; Wang Z
Am J Cancer Res; 2023; 13(5):1640-1655. PubMed ID: 37293166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
